http://www.xconomy.com/seattle/2009/07/15/ovp-leads-15m-series-c-round-for-limerick-biopharma/ Business + Technology in the Exponential Economy Sat, 11 Feb 2012 03:54:18 +0000 hourly 1 http://wordpress.org/?v=3.0.4 http://www.xconomy.com/seattle/2009/07/15/ovp-leads-15m-series-c-round-for-limerick-biopharma/comment-page-1/#comment-71433 Financing Roundup: Limerick BioPharma, America Stem Cell, Femta Pharmaceuticals, Cognition Therapeutics | IguanaBio - A Daily Biotech and Pharma Tabloid - Gossip, News, Research, Humor and Updates on the Latest Events in Biotech and Pharma - Unique, Insig Sun, 19 Jul 2009 13:59:36 +0000 http://www.xconomy.com/?p=33497#comment-71433 [...] Limerick Biopharma, which we profiled back in March 2008, raised $15M from OVP Venture Partners. Limerick’s technology can potentially reduce the tissue exposure of drugs without reducing their intended efficacy. Applications include reduced nausea and vomiting and enhanced cognition (memory tasks) following opioid exposure and attenuated tissue toxicity without impaired graft function in Limerick’s immunesuppression studies. [Xconomy] [...] [...] Limerick Biopharma, which we profiled back in March 2008, raised $15M from OVP Venture Partners. Limerick’s technology can potentially reduce the tissue exposure of drugs without reducing their intended efficacy. Applications include reduced nausea and vomiting and enhanced cognition (memory tasks) following opioid exposure and attenuated tissue toxicity without impaired graft function in Limerick’s immunesuppression studies. [Xconomy] [...]

]]>